XYLASEL
XYLASEL
Authorised
- Xylazine hydrochloride
Product identification
Medicine name:
XYLASEL
Active substance:
- Xylazine hydrochloride
Target species:
-
Cat
-
Dog
Route of administration:
-
Subcutaneous use
-
Intramuscular use
-
Intravenous use
Product details
Active substance and strength:
-
Xylazine hydrochloride23.32/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Cat
-
Intramuscular use
- Dog
- Cat
-
Intravenous use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN05CM92
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Available in:
-
Germany
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Selectavet Dr. Otto Fischer GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Selectavet Dr. Otto Fischer GmbH
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- 400300.00.00
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
